• Media Centre
•  | 
• Purple
•  | 
• Have a word
•  | 
• My Breakthrough

Sitemap

Home
Research Website 2008
What's new	Study finds big survival variations
About breast cancer	What's New? Does drinking alcohol increase the risk of breast cancer? Understanding breast cancer Basic female breast biology Are all lumps cancer? Statistics Lifetime risk Quiz Clinical trials Types of clinical trials Prevention and early detection NHS screening programme Reducing your risk Body Talk Breast awareness Risk factors Established risk factors Alcohol Exposure to ionising radiation Height Breastfeeding Family history and genetic factors Gender Hormone replacement therapy (HRT) Pregnancy The contraceptive pill Weight Age Starting periods early or having a late menopause Exercise Proliferative benign breast conditions Possible risk factors Diet In vitro fertilisation (IVF) treatment Stress Exposure to light at night Childhood risk factors Ethnicity Doubtful risk factors Underwired bras Bumping or bruising the breast Breast implants Abortion Smoking Deodorants and shaving Environmental factors Exposure to non-ionising radiation Diagnosis Breast changes Breast care team The assessment clinic Mammogram Ultrasound Biopsy New diagnostic tests Waiting for test results Benign breast condition diagnosis Breast cysts Fibroadenomas Fibrocystic disease Lipomas Breast pain Proliferative benign breast conditions Breast cancer diagnosis Your feelings What further tests might I have? Biopsy tests Types of primary breast cancer Secondary breast cancer Staging and grading Triple Negative Breast Cancer Treatment Follow up Surgery Lumpectomy Taking a margin Care of your lumpectomy wound Mastectomy Care of your mastectomy wound Lymphoedema Node clearance Node sampling Sentinel node biopsy Breast reconstruction A breast implant A tissue flap Breast prostheses Radiotherapy What to expect with radiotherapy Radioactive wires New ways of giving radiotherapy Treatment planning Side effects of radiotherapy Drug therapy Chemotherapy CMF (cyclophosphamide, methotrexate and 5-fluorouracil) FEC (5-fluorouracil, epirubicin, cyclophosphamide) AC (doxorubicin, cyclophosphamide) Epi-CMF (epirubicin followed by CMF) TAC (docetaxel, doxorubicin and cyclophosphamide) New ways of giving chemotherapy Dealing with chemotherapy side effects Hormone treatment Receptor test Anti-oestrogens (tamoxifen) Aromatase inhibitors Goserelin [Zoladex] Progesterones (Provera, Megace) Antibody treatments Trastuzumab (Herceptin) Complementary therapies Secondary breast cancer Hormone treatment for secondary breast cancer Oophorectomy Radiotherapy for secondary breast cancer Chemotherapy for secondary breast cancer Taxanes (docetaxel [Taxotere], paclitaxel [Taxol]) Vinorelbine [Navelbine] Capecitabine [Xeloda] Gemcitabine [Gemzar] Antibody treatments for secondary breast cancer Trastuzumab (Herceptin) Lapatinib [Tyverb] Family history Breakthrough Genetics Reference Group Understanding breast cancer and risk Lifestyle factors and risk Understanding hereditary breast cancer Explaining a family history What a GP needs to know about your family Which factors in your family give an increased risk of breast cancer? Other patterns of cancer that can be found in families with breast cancer Risk of hereditary breast cancer Prevention and treatment Screening from an earlier age Risk-reducing surgery Genetic testing How are genes inherited? What does having a genetic test involve? What do the results of a genetic test mean? Genetic test for Ashkenazi Jews What happens to your sample when it reaches the laboratory? Research and trials Clinical trials UK Familial Ovarian Cancer Screening Study Early screening study FH01 IBIS- 2 Prevention trial Research studies The POSH study The EMBRACE study Familial Association in Breast Cancer Study Rights and support Your NHS service rights Insurance Family history and insurance Genetic testing and insurance FAQs about genetics and insurance Confidentiality of genetic test results Support services Other sources of information Male breast cancer Signs and symptoms Treatment Diagnosis Gynaecomastia Should I follow a healthy lifestyle? Risk Factors Established Risk Factors Possible Risk Factors Doubtful Risk Factors
What we do	What's New Research Our new research units Breakthrough Research Unit, Edinburgh Breakthrough Research Unit, King’s College London Breakthrough Research Unit, Manchester Our research projects Understanding the biology of the breast Stem cells Scaramanga and abnormal breast development Understanding breast development Modelling breast biology and breast cancer Identifying the causes of breast cancer Breakthrough Generations Study Hodgkin's disease and breast cancer Male breast cancer study Understanding gene function Other genes involved in breast cancer BRCA genes in breast cancer BRCA genes and hereditary breast cancer BRCA genes in non-hereditary breast cancer Understanding tumour formation Cheating cell death Investigating how breast cancers spread Endo180 - The pied piper of breast cancer? Understanding treatments and their side effects Improving diagnosis Nipple fluid - the key to earlier diagnosis? Predicting disease outcome It's all in the genes Predicting response to treatment Developing new treatments New drug targets Drug resistance Treatment for Hereditary Breast Cancer Improving clinical practise Investigating complementary therapies Complementary Therapy Research - Tackling the Challenges Relieving fatigue experienced by cancer patients Complementary Therapy survey findings Preventing breast cancer Our research centre First formal scientific review Meet the scientists Director of the Breakthrough Research Centre Deputy director of the Breakthrough Research Centre Team leaders Interviews What happens in the laboratories Cell culture laboratory Breakthrough Generations laboratory The Microarrary laboratory Our research strategy Scientific advisory committee Breakthrough's research portfolio Conferences Research costs Research grants Major New Funding for UK Breast Cancer Research The Breakthrough Generations Study Campaigning Our key campaigning activities Improving breast cancer services - The Service Pledge for Breast Cancer Improving wig services Reducing radiotherapy waiting times Reducing waiting times for diagnosis The Best Treatment Guidelines for women with breast cancer Improving services for women with a family history Women left waiting in limbo for genetic test results MRI screening available on the NHS Herceptin What has Breakthrough been trying to do? What achievements have been secured? Important developments Screening Saves Lives Campaigning activities Local campaigning Parliamentary work All-Party Parliamentary Group on Breast Cancer Breakthrough Patsy Calton Award Breakthrough Genetics Reference Group Breakthrough Publications Breast Cancer Risk Factor Booklet Breast Cancer Risk Factors: The Facts – for health professionals Breast Cancer Booklet Best Treatment Guidelines The Best Treatment: Your guide to breast cancer treatment in Scotland Abortion and Breast Cancer Risk: The Facts Alcohol and Breast Cancer Risk: The Facts Breastfeeding and Breast Cancer Risk: The Facts Deodorant, Antiperspirants and Breast Cancer Risk: The Facts Soya, Phyto-Oestrogens and Breast Cancer Risk: The Facts Family History Information Leaflet Breast Awareness Information Leaflet HRT and Breast Cancer Risk: the Facts Obesity and Breast Cancer Risk: the Facts Pregnancy and Breast Cancer Risk: the Facts Menarche, Menopause and Breast Cancer Risk: the Facts The Pill and Breast Cancer Risk: the Facts Highlight 02: Biannual Research Update Request Publication Highlight Service Pledge Leads Service Pledge Leads First steps Get in touch with a Pledge Lead A Timetable for Developing your Pledge Keys to success Meeting national requirements Publicising the Pledge Your improvement goals Success stories The Service Pledge at Castle Hill The Service Pledge at Wycombe General Involving Patients with the Pledge Why is patient involvement important? How to involve patients When to involve patients Patient involvement in action What is the Service Pledge? Local Success Stories
You can help	Giving Watch our TV appeal What's New Fundraise in your community The £1,000 challenge Where it all started What kind of support will I receive? Challengers' Wall Why become a £1,000 Challenger? Become a £1000 Challenger Photo gallery Crocus Party 2008 Unveiling of the third Challengers' Wall photo gallery Crocus Party 2006 Crocus Party 2005 Banquet for Breakthrough What is Banquet For Breakthrough? Guide to getting started